Not applicableUnknownNCT00671047What this trial is testingThe Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) StudyWho this might be right forSystemic Lupus Erythematosus XDx 1,000
Early research (Phase 1)Looking for participantsNCT06465147What this trial is testingREACT-01: Reversing Autoimmunity Through Cell TherapyWho this might be right forSystemic Lupus Erythematosus Seattle Children's Hospital 12
Large-scale testing (Phase 3)Study completedNCT00712933What this trial is testingA Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057Who this might be right forSystemic Lupus Erythematosus Human Genome Sciences Inc., a GSK Company 738
Large-scale testing (Phase 3)UnknownNCT05236491What this trial is testingCOvid-19 Vaccine Booster in Immunocompromised Rheumatic DiseasesWho this might be right forRheumatoid ArthritisAutoimmune Rheumatologic DiseaseSystemic Lupus Erythematosus+6 more Paul R Fortin 287
Testing effectiveness (Phase 2)Study completedNCT04433585What this trial is testingLY3471851 in Adults With Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Nektar Therapeutics 291
Not applicableNot Yet RecruitingNCT07716462What this trial is testingHome-Based High-Intensity Interval Training in Systemic Lupus ErythematosusWho this might be right forSystemic Lupus ErthematosusFatigueExercise Training University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Ended earlyNCT05123586What this trial is testingA IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Eli Lilly and Company 85
Early research (Phase 1)WithdrawnNCT02920424What this trial is testingEvaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic Janssen Research & Development, LLC
Early research (Phase 1)WithdrawnNCT06752876What this trial is testingCRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)Who this might be right forSystemic Lupus ErythematosusLupusLupus Erythematosus+1 more Caribou Biosciences, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT00732940What this trial is testingPhase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus Human Genome Sciences Inc. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05039840What this trial is testingEfficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Sanofi 109
Testing effectiveness (Phase 2)Looking for participantsNCT07185269What this trial is testingThe Purpose of This Study is to Evaluate the Efficacy and Safety of 626 in the Treatment of SLEWho this might be right forSystemic Lupus Erythematosus (SLE) Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 198
Not applicableStudy completedNCT00982670What this trial is testingThe Metabolic Syndrome in Patients With Systemic Lupus ErythematosusWho this might be right forMetabolic SyndromeCardiovascular Risk FactorsSystemic Lupus Erythematosus Far Eastern Memorial Hospital 100
Early research (Phase 1)Looking for participantsNCT07607964What this trial is testingAssess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)Who this might be right forSystemic Lupus ErythematosusRheumatoid Arthritis AbbVie 30
Large-scale testing (Phase 3)Study completedNCT01261793What this trial is testingStudy of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)Who this might be right forSystemic Lupus Erythematosus UCB Pharma 791
Not applicableStudy completedNCT03370263What this trial is testingBENLYSTA® Special Drug Use InvestigationWho this might be right forSystemic Lupus Erythematosus GlaxoSmithKline 1,514
Testing effectiveness (Phase 2)Looking for participantsNCT07509892What this trial is testingA Clinical Trial on the Efficacy and Safety of TQH3906 in the Treatment of Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 198
Early research (Phase 1)Study completedNCT04128579What this trial is testingStudy of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative NephritisWho this might be right forLupus ErythematosusLupus Nephritis Biocon Limited 52
Testing effectiveness (Phase 2)Study completedNCT01351662What this trial is testingBalancing Lupus Experiences With Stress StrategiesWho this might be right forSystemic Lupus Erythematosus Medical University of South Carolina 30
Large-scale testing (Phase 3)Ended earlyNCT03616912What this trial is testingBaricitinib (LY3009104) in Participants With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Eli Lilly and Company 830